Publications
INVESTING IN AFRICA’S YOUTH – HOW THE EU CAN BETTER SUPPORT ADOLESCENT SRHR
In many African countries, young people are a majority, often accounting for more than 60 percent of the population. Africa’s youth population is expected to continue to grow throughout the remainder of the 21st century, and to more than double its current levels by 2055. In this context, there is no development without youth.
DSW ADVOCACY STRATEGY
When governments prioritise investments and improve policies for young people (especially girls and young women), this has a positive impact on the rest of their lives and indeed whole societies. By gaining the support of decision-makers for our cause, we can achieve more.
DSW FINANCE REPORT 2018
Within the scope of the compilation of the annual financial statements, the Foundation’s net assets, financial position, and results from operations, as well as the maintenance of the Foundation’s endowment capital, and its use, were audited and verified.
EDCTP 3 POSITION PAPER
Call for a dedicated R&I instrument for diseases of poverty under FP9: Building on the success of EDCTP.
EU SUPPORT FOR GLOBAL HEALTH R&I – RECOMMENDATIONS FOR THE FUTURE FP9
Today one billion people worldwide are affected by poverty-related and neglected diseases (PRNDs), including major diseases like HIV&AIDS, tuberculosis, and malaria, and a range of neglected infectious diseases.
YOUNG PEOPLE AND POVERTY-RELATED NEGLECTED DISEASES
Adolescence and youth* is often thought to be the healthiest time of life. Yet, more than half of the world’s 1.8 billion young people aged 10–24 years grow up in ‘multi-burden countries’, characterised by high levels of adverse health outcomes.
ADOLESCENCE AND YOUTH – THE HEALTHIEST TIME OF LIFE?
More than half of the world’s 1.8 billion young people aged 10–24 years grow up in so-called ‘multi-burden countries’, with high levels of adverse health outcomes.
WORKING TOWARDS 2030 – DSW’S STRATEGIC DIRECTION FOR OUR GLOBAL FUTURE
One thing is very clear: young people make up the biggest part of the world’s population, especially in countries affected by extreme poverty.
GOING FURTHER TOGETHER – THE CASE FOR EUROPEAN UNION PARTNERSHIP WITH AFRICA ON REGULATORY HARMONIZATION
The regulation of health products is an essential aspect of a functioning health system. Unfortunately, many low- and middle-income countries (LMICs) lack sustained funding and the technical expertise necessary to robustly and comprehensively regulate the research and registration of new health technologies.
INVESTING IN INNOVATION TO ACHIEVE THE SDGS
Science Technology and Innovation (STI) will play a central role in accomplishing the SDGs, which cannot be achieved with today’s technologies. Supportive policies, bold investment, and coordinated financing in the area of STI will be critical to ensuring the EU’s leadership in sustainable development.